Content area
Full Text
The FDA has lowered the boom on a Bayer finished products plant in Germany. The agency says the plant handled its cleanup so poorly that one of its customers had to recall products because of cross-contamination.
The German drugmaker has indicated that work related to the warning letter, which was issued in November but posted by the FDA only Tuesday, is affecting supplies of some of Bayers’s established products, but not products shipped to the U.S. That portfolio includes drugs like its...